Researchers seeking participants
From time to time the MS Trust is asked by organisations to share information about studies that are about to start, or have started, or are wanting to recruit people. These organisations include pharma companies, companies working on their behalf known as Clinical Research Organisations, healthcare professionals and academic researchers.
In the event of this happening and in the interest of people with MS the MS Trust will seek confirmation from the organisation or individual that the study has the appropriate ethical approval and that any information or advert that we are being asked to share with you has ethical approval. In addition we will ensure that contact details are obtained should further information be required.
This is the only action that the MS Trust will take and we assume no further responsibility for the information shown.
Please note if you do require any further information about items posted here please use the contact details provided. The MS Trust has no further information and should not be contacted.
Breaking bad news well in people with multiple sclerosis
August 2011
Researchers at the University of Glasgow are carrying out a research project exploring communicating a diagnosis of multiple sclerosis.
Experiences of having a friend or family member with multiple sclerosis
April 2011
A group based at the University of Oxford are conducting research into the experience of caring for someone with MS.
Role of infection in bladder symptoms
March 2011
Take part in a study which is investigating the role of infection in the development of bladder symptoms.
The experience of support groups for people diagnosed with multiple sclerosis
January 2011
Take part in a survey which is investigating the relationship between being part of a support group with health and well-being.
Research Ethics Committee Lay Members
January 2011
The National Research Ethics Service is trying to recruit lay members to Research Ethics Committees in the London area.
Clinical trial of a new drug under development by Apitope Technology
April 2010
ATX-MS-1467 is a new drug under development by Apitope Technology (Bristol) Ltd as a potential new treatment for patients with relapsing multiple sclerosis.
Researchers are currently seeking 18-55 year old male and female patients with relapsing remitting MS to join in the trial currently underway at several study sites in the UK.